Top

Published in:

01-05-2018 | Original Article

Patient-clinician communication among patients with stage I lung cancer

Authors: Shannon M. Nugent, Sara E. Golden, Charles R. Thomas Jr, Mark E. Deffebach, Mithran S. Sukumar, Paul H. Schipper, Brandon H. Tieu, Drew Moghanaki, Juan Wisnivesky, Christopher Slatore

Published in: Supportive Care in Cancer | Issue 5/2018

Abstract

Purpose

Limited data exist about patient-centered communication (PCC) and patient-centered outcomes among patients who undergo surgery or stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC). We aimed to examine the relationship between PCC and decision-making processes among NSCLC patients, using baseline data from a prospective, multicenter study.

Methods

Patients with stage 1 NSCLC completed a survey prior to treatment initiation. The survey assessed sociodemographic characteristics, treatment decision variables, and patient psychosocial outcomes: health-related quality of life (HRQOL), treatment self-efficacy, decisional conflict, and PCC.

Results

Fifty-two percent (n = 85) of 165 individuals planned to receive SBRT. There were no baseline differences detected on patient psychosocial outcomes between those who planned to receive SBRT or surgery. All participants reported high HRQOL (M = 72.5, SD = 21.3) out of 100, where higher scores indicate better functioning; high self-efficacy (M = 1.5, SD = 0.5) out of 6, where lower numbers indicate higher self-efficacy; minimal decisional conflict (M = 15.2, SD = 12.7) out of 100, where higher scores indicate higher decisional conflict; and high levels of patient-centered communication (M = 2.4, SD = 0.8) out of 7 where higher scores indicate worse communication. Linear regression analyses adjusting for sociodemographic and clinical variables showed that higher quality PCC was associated with higher self-efficacy (β = 0.17, p = 0.03) and lower decisional conflict (β = 0.42, p < 0.001).

Conclusions

Higher quality PCC was associated with higher self-efficacy and lower decisional conflict. Self-efficacy and decisional conflict may influence subsequent health outcomes. Therefore, our findings may inform future research and clinical programs that focus on communication strategies to improve these outcomes.

Available only for authorised users

American Cancer Society (2016) Cancer facts and statistics. Cancer.org. http://www.cancer.org/research/cancerfactsstatistics/index. Accessed 22 Feb 2017

U.S. Preventative Services Task Force (2013) Lung cancer: screening. Uspreventitiveservicetaskforce.org. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening. Accessed 22 Feb 2017

Humphrey L, Deffebach M, Pappas M, et al (2013) U.S. screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation. Agency for Healthcare Research and Quality (US). Evidence Synthesis no. 105. AHRQ publication no. 13-05196-EF-1. Rockville, Maryland

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB (2013) Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5_suppl):e78S–e92SCrossRefPubMedPubMedCentral

Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT (2007) Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132(3):161S–177S. https://doi.org/10.1378/chest.07-1359 CrossRefPubMed

Chang JY, Roth JA (2007) Stereotactic body radiation therapy for stage I non-small cell lung cancer. Thorac Surg Clin 17(2):251–259. https://doi.org/10.1016/j.thorsurg.2007.03.011 CrossRefPubMed

Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S (2010) Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer 116(2):406–414. https://doi.org/10.1002/cncr.24759 CrossRefPubMed

Haque W, Szeja S, Tann A, Kalra S, Teh BS (2016) Changes in treatment patterns and overall survival in patients with early-stage non-small cell lung cancer in the United States after the incorporation of stereotactic ablative radiation therapy. J Clin Oncol 00(00):1–8

Nyman J, Johansson KA, Hulten U (2006) Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—mature results for medically inoperable patients. Lung Cancer 51(1):97–103. https://doi.org/10.1016/j.lungcan.2005.08.011 CrossRefPubMed

10.

Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11):1070–1076. https://doi.org/10.1001/jama.2010.261 CrossRefPubMedPubMedCentral

11.

Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S (2010) Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 28(35):5153–5159. https://doi.org/10.1200/JCO.2010.30.0731 CrossRefPubMed

12.

Pan H, Rose BS, Simpson DR, Mell LK, Mundt AJ, Lawson JD (2013) Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol 36(3):269–272. https://doi.org/10.1097/COC.0b013e3182467db3 CrossRefPubMedPubMedCentral

13.

Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD (2011) A survey of stereotactic body radiotherapy use in the United States. Cancer 117(19):4566–4572. https://doi.org/10.1002/cncr.26067 CrossRefPubMedPubMedCentral

14.

Tipton K, Launders JH, Inamdar R, Miyamoto C, Schoelles K (2011) Stereotactic body radiation therapy: scope of the literature. Ann Intern Med 154(11):737–745. https://doi.org/10.7326/0003-4819-154-11-201106070-00343 CrossRefPubMed

15.

Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJM, McRae SE, Widder J, Feng L, van den Borne BEEM, Munsell MF, Hurkmans C, Berry DA, van Werkhoven E, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJA, Carpenter LS, de Jaeger K, Komaki R, Slotman BJ, Smit EF, Roth JA (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials. Lancet Oncol 16(6):630–637. https://doi.org/10.1016/S1470-2045(15)70168-3 CrossRefPubMedPubMedCentral

16.

Louie AV, Werkhoven EV, Chen H et al (2015) Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: results from the ROSEL multicenter randomized trial. Radiother and Oncologia 117(1):44–48CrossRef

17.

LM W, Austin J, Hamilton JG et al (2012) Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psycho-Oncologia 21(11):1175–1184CrossRef

18.

Mosher CE, Lipkus I, Sloane R, Snyder DC, Lobach DF, Demark-Wahnefried W (2013) Long-term outcomes of the FRESH START trial: exploring the role of self-efficacy in cancer survivors’ maintenance of dietary practices and physical activity. Psycho-Oncologia 22(4):876–885CrossRef

19.

Miller SM, Bowen DJ, Croyle RT, Rowland JH (2009) Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policy makers, 1st edn. American Psychological Association, Washington, DC. https://doi.org/10.1037/14499-000 CrossRef

20.

Kaplan AL, Crespi CM, Saucedo JD, Connor SE, Litwin MS, Saigal CS (2014) Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial. Cancer 120(17):2721–2727. https://doi.org/10.1002/cncr.28755 CrossRefPubMedPubMedCentral

21.

Slatore CG, Press N, DH A, Curtis JR, Wiener RS, Ganzini L (2013) What the heck is a “nodule”? A qualitative study of veterans with pulmonary nodules. Ann Am Thorac Soc 10(4):330–335. https://doi.org/10.1513/AnnalsATS.201304-080OC CrossRefPubMedPubMedCentral

22.

Venetis MK, Robinson JD, Turkiewicz KL, Allen M (2009) An evidence base for patient-centered cancer care: a meta-analysis of studies of observed communication between cancer specialists and their patients. Patient Educ Couns 77(3):379–383. https://doi.org/10.1016/j.pec.2009.09.015 CrossRefPubMed

23.

Epstein EM, Duberstein PR, Fenton JJ et al (2017) Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncol 3(1):92–100. https://doi.org/10.1001/jamaoncol.2016.4373 PubMedPubMedCentral

24.

Tariq SH, Tumosa N, Chibnall JT, Perry MH 3rd, Morley JE (2006) Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry 14(11):900–910. https://doi.org/10.1097/01.JGP.0000221510.33817.86 CrossRefPubMed

25.

O’Connor, AM (1993) User manual—Decisional Conflict Scale. Ottawa Hospital Research Institute. Ottawa, Ontario [updated 2010]

26.

Wolf MS, Chang CH, Davis T, Makoul G (2005) Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer). Patient Educ Couns 57(3):333–341. https://doi.org/10.1016/j.pec.2004.09.005 CrossRefPubMed

27.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. https://doi.org/10.1093/jnci/85.5.365 CrossRefPubMed

28.

Dinescu FV, Tiple C, Chirila M, Muresan R, Drugan T, Cosgarea M (2016) Evaluation of health-related quality of life with EORTC QLQ-C30 and QLQ-H&N35 in Romanian laryngeal cancer patients. Eur Arch Otorhinolaryngol 273(9):2735–2740. https://doi.org/10.1007/s00405-015-3809-0 CrossRefPubMed

29.

Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30a(5):635–642CrossRefPubMed

30.

Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144. https://doi.org/10.1200/JCO.1998.16.1.139 CrossRefPubMed

31.

Degner LF, Sloan JA, Venkatesh P (1997) The control preferences scale. Can J Nurs Res 29(3):21–43PubMed

32.

Powell H, McCaffery K, Murphy VE, Hensley MJ, Clifton VL, Giles W, Gibson PG (2011) Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma. J Asthma 48(10):1032–1040. https://doi.org/10.3109/02770903.2011.631239 CrossRefPubMed

33.

Hudon C, Fortin M, Haggerty JL, Lambert M, Poitras ME (2011) Measuring patients’ perceptions of patient-centered care: a systematic review of tolls for family medicine. Ann Fam Med 9(2):155–164. https://doi.org/10.1370/afm.1226 CrossRefPubMedPubMedCentral

34.

Little P, Everitt H, Williamson I, Warner G, Moore M, Gould C, Ferrier K, Payne S (2001) Observational study of effect of patient centeredness and positive approach on outcomes of general practice consultations. BMJ 323(7318):908–911. https://doi.org/10.1136/bmj.323.7318.908 CrossRefPubMedPubMedCentral

35.

Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA (1990) The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 65(5):1242–1254. https://doi.org/10.1002/1097-0142(19900301)65:5<1242::AID-CNCR2820650535>3.0.CO;2-1 CrossRefPubMed

36.

Schwarzer R, Lippke S, Luszczynska A (2011) Mechanisms of health behavior change in persons with chronic illness or disability: the Health Action Process Approach (HAPA). Rehabil Psychol 56(3):161–170. https://doi.org/10.1037/a0024509 CrossRefPubMed

37.

Yang LY, Manahs DS, Howard AF, Olson RA. (2017) Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication. Support Care Cancer

Title: Patient-clinician communication among patients with stage I lung cancer
Authors: Shannon M. Nugent
Sara E. Golden
Charles R. Thomas Jr
Mark E. Deffebach
Mithran S. Sukumar
Paul H. Schipper
Brandon H. Tieu
Drew Moghanaki
Juan Wisnivesky
Christopher Slatore
Publication date: 01-05-2018
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 5/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3992-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2018

Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study

Racial differences in symptom management experiences during breast cancer treatment

Breast cancer survivors: return to work and wage loss in selected hospitals in Malaysia

Nurses attitudes and practices towards provision of survivorship care for people with a haematological cancer on completion of treatment

Burden of oral mucositis in stem cell transplant patients—the patients’ perspective

Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial

Keynote webinar | Spotlight on antibody–drug conjugates in cancer